ENABLE INJECTIONS, INC
Wearable on-body drug delivery platform for high-volume pharmaceutical administration
- Sector
- Medtech
- Headquarters
- CINCINNATI, OH
- Founded
- 2010
- Latest Form D
- $30M, Jan 2026
- Total capital
- $230M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $230M
- 11 Form D · last Jan 2026
- 10 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- first 2026
- Rank in peer group#498 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 11th filing$30M
- Private capital raisedForm D · SEC · 10th filing$150M
- Private capital raisedForm D · SEC · 9th filing$30.7M
- Private capital raisedForm D · SEC · 8th filing$10M
- Private capital raisedForm D · SEC · 7th filing$23K
- Private capital raisedForm D · SEC · 6th filing$2M
- Offering registeredForm D · SEC · 5th filing$10K
- Offering registeredForm D · SEC · 4th filing$100K
- Private capital raisedForm D · SEC · 3rd filing$247K
- Private capital raisedForm D · SEC · 2nd filing$5M
- Private capital raisedForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#498 · top 45%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Beckie J. RobertsonDirectorNamed in SEC Form D filings
- Daniel D. von AllmenDirectorNamed in SEC Form D filings
- David D. KroekelExecutive OfficerNamed in SEC Form D filings
- Erik D. FalkDirectorNamed in SEC Form D filings
- Jim J. CollinsDirectorNamed in SEC Form D filings
- John J. DeFordDirectorNamed in SEC Form D filings
Show all 18 people
- John J RiceDirectorNamed in SEC Form D filings
- Karen J RobardsDirectorNamed in SEC Form D filings
- Mark A. CollarDirectorNamed in SEC Form D filings
- Matt D. HuddlestonExecutive OfficerNamed in SEC Form D filings
- Michael HoovenExecutive OfficerNamed in SEC Form D filings
- Nigel J. SheailDirectorNamed in SEC Form D filings
- Norman D. WeldonDirectorNamed in SEC Form D filings
- Richard D. D'AugustineDirectorNamed in SEC Form D filings
- Simone A. SongDirectorNamed in SEC Form D filings
- Susan SpiesExecutive OfficerNamed in SEC Form D filings
- Timothy FlahertyExecutive OfficerNamed in SEC Form D filings
- Vickie J. CappsDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 1- New patentVial Transfer and Injection Apparatus and MethodUSPTOUS 12,746,331
Related companies, and why
- INREDOX LLCSimilar federal contract value in Medtech · null in contracts
- LiveFocus LLCSimilar federal contract value in Medtech · null in contracts
- Blue Resonance, LLCSimilar federal contract value in Medtech · null in contracts
- AppliedVR, Inc.Similar federal contract value in Medtech · null in contracts
- BOSE CORPORATIONSimilar federal contract value in Medtech · null in contracts
- AESTAS PHARMA INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .